Rein Therapeutics logo

Rein Therapeutics Share Price (NASDAQ: RNTX)

$1.38

0.25

(22.12%)

Last updated on

Check the interactive Rein Therapeutics Stock chart to analyse performance

Rein Therapeutics stock performance

as on August 30, 2025 at 1:26 am IST

  • Today's Low:$1.19
    Today's High:$1.40

    Day's Volatility :15.36%

  • 52 Weeks Low:$1.04
    52 Weeks High:$3.50

    52 Weeks Volatility :70.29%

Rein Therapeutics Stock Returns

PeriodRein Therapeutics IncIndex (Russel 2000)
3 Months
-27.46%
0.0%
6 Months
-26.32%
0.0%
1 Year
-48.15%
0.0%
3 Years
-58.85%
-4.7%

Rein Therapeutics Inc Key Stats

Check Rein Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.13
Open
$1.185
Today's High
$1.4
Today's Low
$1.185
Market Capitalization
$52.9M
Today's Volume
$227.0K
52 Week High
$3.5
52 Week Low
$1.04
Revenue TTM
$0.0
EBITDA
$-29.5M
Earnings Per Share (EPS)
$-2.88
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-54.95%

Stock Returns calculator for Rein Therapeutics Stock including INR - Dollar returns

The Rein Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rein Therapeutics investment value today

Current value as on today

₹56,395

Returns

₹43,605

(-43.6%)

Returns from Rein Therapeutics Stock

₹48,889 (-48.89%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Rein Therapeutics Stock

-33%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Rein Therapeutics Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Rein Therapeutics Stock

Rating
Trend

Rein Therapeutics Share Price Target

What analysts predicted

Upside of 842.03%

Target:

$13.00

Current:

$1.38

Rein Therapeutics share price target is $13.00, a slight Upside of 842.03% compared to current price of $1.38 as per analysts' prediction.

Rein Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, RNTX stock has moved up by 10.2%
  • RNTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 114.3%
  • RNTX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 175.8%

Rein Therapeutics Technicals Summary

Sell

Neutral

Buy

Rein Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Rein Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Rein Therapeutics Inc logo
26.13%
-26.32%
-48.15%
-58.85%
-94.26%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Rein Therapeutics Inc

Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). It also offers LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The company's pipeline also includes preclinical programs targeting cystic fibrosis and a peptide program focused on the caveolin-1 protein for systemic fibrosis indications; and LTI-05, an epithelial sodium channel for the treatment of cystic fibrosis. The company was formerly known as Aileron Therapeutics, Inc. and changed its name to Rein Therapeutics Inc. in February 2007. The company was incorporated in 2001 and is headquartered in Austin, Texas.
Organization
Rein Therapeutics
Employees
11
CEO
Dr. James Brian Windsor Ph.D.
Industry
Miscellaneous

Key Management of Rein Therapeutics Inc

NameTitle
Dr. James Brian Windsor Ph.D.
CEO, President & Director
Mr. Timothy M. Cunningham CPA, M.B.A.
Interim CFO & Principal Accounting Officer
Dr. Cory M. Hogaboam Ph.D.
Chief Scientific Officer

Important FAQs about investing in RNTX Stock from India :

What is Rein Therapeutics share price today?

Rein Therapeutics share price today is $1.38 as on at the close of the market. Rein Therapeutics share today touched a day high of $1.40 and a low of $1.19.

What is the 52 week high and 52 week low for Rein Therapeutics share?

Rein Therapeutics share touched a 52 week high of $3.50 and a 52 week low of $1.04. Rein Therapeutics stock price today i.e. is closed at $1.38, lower by 60.57% versus the 52 week high.

How to invest in Rein Therapeutics Stock (RNTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Rein Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rein Therapeutics Shares that will get you 1.0870 shares as per Rein Therapeutics share price of $1.38 per share as on August 30, 2025 at 1:26 am IST.

What is the minimum amount required to buy Rein Therapeutics Stock (RNTX) from India?

Indian investors can start investing in Rein Therapeutics (RNTX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Rein Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Rein Therapeutics share’s latest price of $1.38 as on August 30, 2025 at 1:26 am IST, you will get 7.2464 shares of Rein Therapeutics. Learn more about fractional shares .

What are the returns that Rein Therapeutics has given to Indian investors in the last 5 years?

Rein Therapeutics stock has given -94.26% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?